Bakary Fofana
Bamako, BKO, Mali
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Decreased dihydroartemisinin-piperaquine protection against recurrent malaria associated with Plasmodium falciparum plasmepsin 3 copy number variation in Africa.
Journal: Nature communications
Published: July 02, 2024
Pharmacokinetics of Ganaplacide and Lumefantrine in Adults, Adolescents, and Children with Plasmodium falciparum Malaria Treated with Ganaplacide Plus Lumefantrine Solid Dispersion Formulation: Analysis of Data from a Multinational Phase 2 Study.
Journal: Journal of clinical pharmacology
Published: June 18, 2024
Population-specific variations in KCNH2 predispose patients to delayed ventricular repolarization upon dihydroartemisinin-piperaquine therapy.
Journal: Antimicrobial agents and chemotherapy
Published: March 28, 2024
Complexity of Plasmodium falciparum infection and genetic variations associated with differences in parasite clearance time in two Malian villages.
Journal: Research square
Published: July 18, 2023
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Journal: The Lancet. Infectious diseases
Published: January 19, 2023
A Novel Ex Vivo Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes.
Journal: Antimicrobial agents and chemotherapy
Published: November 02, 2022
IFNγ, TNFα polymorphisms and IFNγ serum levels are associated with the clearance of drug-resistant P. falciparum in Malian children.
Journal: Cytokine
Published: October 05, 2022
Variation in neutrophil levels and artemisinin-based combination therapy efficacy in West-Africa.
Journal: Journal of infection in developing countries
Published: July 10, 2022
Hepatic safety and tolerability of cipargamin (KAE609), in adult patients with Plasmodium falciparum malaria: a randomized, phase II, controlled, dose-escalation trial in sub-Saharan Africa.
Journal: Malaria journal
Published: August 12, 2021
Differential Incidence of Malaria in Neighboring Villages in a High-Transmission Setting of Southern Mali.
Journal: The American journal of tropical medicine and hygiene
Published: July 13, 2021
Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: July 06, 2021
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso.
Journal: Antimicrobial agents and chemotherapy
Published: June 01, 2021
Last Updated: 09/26/2026